ÂÜÀòÂÒÂ×

Julie Waldron is an experienced leader in pharmacovigilance and regulatory affairs, currently serving as Vice President of Business and Process Optimization at PrimeVigilance since January 2024. Previously, Julie held senior director roles at Thermo Fisher Scientific and PPD, as well as vice president positions at Syneos Health, where responsibilities included managing Individual Case Safety Reports (ICSRs) and ensuring compliance with global safety regulations. Julie's extensive experience also includes executive and director-level roles at INC Research and global director responsibilities at MDS Pharma Services, beginning with a foundational role as a Product Safety Scientist at Eli Lilly. Julie's educational background includes attending Clitheroe Royal Grammar School for Girls and Heathfield Prep School in Blackburn.